Danaher DHR
NYSE DHR
$214.05 +2.31 (+1.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Danaher (DHR) Gains from Sales and Divestitures (2020)

Updated

Danaher (DHR) recorded Gains from Sales and Divestitures of $400,000 in Q4 2020.

Analysis

Danaher (DHR) Gains from Sales and Divestitures (2020) Analysis & Trends

For FY2020, Danaher reported Gains from Sales and Divestitures of $455 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Agilent Technologies 47.29 Bn 40.18 Bn 1.04 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 400,000.00
Jul 3, 2020 455.00 Mn
API Access

Danaher Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DHR&period=max&api_key=YOUR_API_KEY